The Long Goodbye – Alzheimer’s Society film 

A survey has been launched for unpaid carers who have a health condition that looks at their experiences of applying to, and being in, paid work.  The survey forms part of research being undertaken by Carers Trust, Simplyhealth and Business in the Community to look at carers’ experiences of balancing their health needs with employment,…

Scottish Opera has revived its Memory Spinners project, which has been suspended during the pandemic, to bring music and art to people with dementia.  In weekly sessions designed to engage people with dementia, taking place at St Columba’s church in Glasgow and the Byre in St Andrews, rehearsals and visual arts activities build towards a…

A major research study published in the BMJ has shown that people were at higher risk of developing dementia following a Covid-19 infection.  Scientists found that almost a third of older adults (32%) who got Covid-19 in 2020 went on to develop at least one new medical condition in the months after infection, compared with…

A new blood test developed at Pittsburgh University may hold the key to diagnosing Alzheimer’s disease relatively inexpensively.  Results published in the journal Brain show that the test reliably detects a biomarker called “brain-derived tau”, using an antibody that selectively binds this protein found specifically in the blood of people with Alzheimer’s.  “At present, diagnosing…

The BBC’s Panorama programme has aired a documentary on dementia.  The BBC says of the content: “Around 900,000 people in the UK are living with dementia, and two-thirds of them have Alzheimer’s. For patients and their loved ones, it’s a devastating disease. But two new drugs have shown, for the first time, that the relentless…

Further to The National Institute for Health and Care Excellence (NICE) publishing draft guidance for public consultation about Alzheimer’s treatments donanemab and lecanemab (that we reported on here: https://journalofdementiacare.co.uk/nice-publish-further-draft-guidance-on-lecanemab-and-donanemab), NICE has published final draft guidance that continues to not recommend donanemab and lecanemab for use on the NHS.    Explaining the decision, Helen Knight, NICE Director…